Global Hereditary Angioedema Therapeutic Market Research Report 2023

Report ID: 2009675 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous
        1.2.3 Subcutaneous
        1.2.4 Oral
    1.3 Market by Application
        1.3.1 Global Hereditary Angioedema Therapeutic Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hereditary Angioedema Therapeutic Market Perspective (2017-2028)
    2.2 Hereditary Angioedema Therapeutic Growth Trends by Region
        2.2.1 Hereditary Angioedema Therapeutic Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hereditary Angioedema Therapeutic Historic Market Size by Region (2017-2022)
        2.2.3 Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2023-2028)
    2.3 Hereditary Angioedema Therapeutic Market Dynamics
        2.3.1 Hereditary Angioedema Therapeutic Industry Trends
        2.3.2 Hereditary Angioedema Therapeutic Market Drivers
        2.3.3 Hereditary Angioedema Therapeutic Market Challenges
        2.3.4 Hereditary Angioedema Therapeutic Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue
        3.1.1 Global Top Hereditary Angioedema Therapeutic Players by Revenue (2017-2022)
        3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2017-2022)
    3.2 Global Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hereditary Angioedema Therapeutic Revenue
    3.4 Global Hereditary Angioedema Therapeutic Market Concentration Ratio
        3.4.1 Global Hereditary Angioedema Therapeutic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hereditary Angioedema Therapeutic Revenue in 2021
    3.5 Hereditary Angioedema Therapeutic Key Players Head office and Area Served
    3.6 Key Players Hereditary Angioedema Therapeutic Product Solution and Service
    3.7 Date of Enter into Hereditary Angioedema Therapeutic Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Angioedema Therapeutic Breakdown Data by Type
    4.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Type (2017-2022)
    4.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2023-2028)
5 Hereditary Angioedema Therapeutic Breakdown Data by Application
    5.1 Global Hereditary Angioedema Therapeutic Historic Market Size by Application (2017-2022)
    5.2 Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hereditary Angioedema Therapeutic Market Size (2017-2028)
    6.2 North America Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
    6.3 North America Hereditary Angioedema Therapeutic Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hereditary Angioedema Therapeutic Market Size (2017-2028)
    7.2 Europe Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
    7.3 Europe Hereditary Angioedema Therapeutic Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hereditary Angioedema Therapeutic Market Size (2017-2028)
    8.2 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hereditary Angioedema Therapeutic Market Size (2017-2028)
    9.2 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
    9.3 Latin America Hereditary Angioedema Therapeutic Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hereditary Angioedema Therapeutic Market Size (2017-2028)
    10.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 BioCryst Pharma
        11.1.1 BioCryst Pharma Company Detail
        11.1.2 BioCryst Pharma Business Overview
        11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Introduction
        11.1.4 BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.1.5 BioCryst Pharma Recent Development
    11.2 Ionis Pharma
        11.2.1 Ionis Pharma Company Detail
        11.2.2 Ionis Pharma Business Overview
        11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Introduction
        11.2.4 Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.2.5 Ionis Pharma Recent Development
    11.3 Pharming Group
        11.3.1 Pharming Group Company Detail
        11.3.2 Pharming Group Business Overview
        11.3.3 Pharming Group Hereditary Angioedema Therapeutic Introduction
        11.3.4 Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.3.5 Pharming Group Recent Development
    11.4 CSL Limited
        11.4.1 CSL Limited Company Detail
        11.4.2 CSL Limited Business Overview
        11.4.3 CSL Limited Hereditary Angioedema Therapeutic Introduction
        11.4.4 CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.4.5 CSL Limited Recent Development
    11.5 Shire
        11.5.1 Shire Company Detail
        11.5.2 Shire Business Overview
        11.5.3 Shire Hereditary Angioedema Therapeutic Introduction
        11.5.4 Shire Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.5.5 Shire Recent Development
    11.6 Attune Pharma
        11.6.1 Attune Pharma Company Detail
        11.6.2 Attune Pharma Business Overview
        11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Introduction
        11.6.4 Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.6.5 Attune Pharma Recent Development
    11.7 Adverum Biotechnologies
        11.7.1 Adverum Biotechnologies Company Detail
        11.7.2 Adverum Biotechnologies Business Overview
        11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Introduction
        11.7.4 Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.7.5 Adverum Biotechnologies Recent Development
    11.8 KalVista Pharma
        11.8.1 KalVista Pharma Company Detail
        11.8.2 KalVista Pharma Business Overview
        11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Introduction
        11.8.4 KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022)
        11.8.5 KalVista Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Hereditary Angioedema Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous
    Table 3. Key Players of Subcutaneous
    Table 4. Key Players of Oral
    Table 5. Global Hereditary Angioedema Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Hereditary Angioedema Therapeutic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Hereditary Angioedema Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Hereditary Angioedema Therapeutic Market Share by Region (2017-2022)
    Table 9. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Hereditary Angioedema Therapeutic Market Share by Region (2023-2028)
    Table 11. Hereditary Angioedema Therapeutic Market Trends
    Table 12. Hereditary Angioedema Therapeutic Market Drivers
    Table 13. Hereditary Angioedema Therapeutic Market Challenges
    Table 14. Hereditary Angioedema Therapeutic Market Restraints
    Table 15. Global Hereditary Angioedema Therapeutic Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Hereditary Angioedema Therapeutic Market Share by Players (2017-2022)
    Table 17. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2021)
    Table 18. Ranking of Global Top Hereditary Angioedema Therapeutic Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Hereditary Angioedema Therapeutic Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Hereditary Angioedema Therapeutic Product Solution and Service
    Table 22. Date of Enter into Hereditary Angioedema Therapeutic Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2017-2022)
    Table 26. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Hereditary Angioedema Therapeutic Revenue Market Share by Type (2023-2028)
    Table 28. Global Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2017-2022)
    Table 30. Global Hereditary Angioedema Therapeutic Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Hereditary Angioedema Therapeutic Revenue Market Share by Application (2023-2028)
    Table 32. North America Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Hereditary Angioedema Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Hereditary Angioedema Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Hereditary Angioedema Therapeutic Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Hereditary Angioedema Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Country (2023-2028) & (US$ Million)
    Table 42. BioCryst Pharma Company Detail
    Table 43. BioCryst Pharma Business Overview
    Table 44. BioCryst Pharma Hereditary Angioedema Therapeutic Product
    Table 45. BioCryst Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 46. BioCryst Pharma Recent Development
    Table 47. Ionis Pharma Company Detail
    Table 48. Ionis Pharma Business Overview
    Table 49. Ionis Pharma Hereditary Angioedema Therapeutic Product
    Table 50. Ionis Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 51. Ionis Pharma Recent Development
    Table 52. Pharming Group Company Detail
    Table 53. Pharming Group Business Overview
    Table 54. Pharming Group Hereditary Angioedema Therapeutic Product
    Table 55. Pharming Group Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 56. Pharming Group Recent Development
    Table 57. CSL Limited Company Detail
    Table 58. CSL Limited Business Overview
    Table 59. CSL Limited Hereditary Angioedema Therapeutic Product
    Table 60. CSL Limited Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 61. CSL Limited Recent Development
    Table 62. Shire Company Detail
    Table 63. Shire Business Overview
    Table 64. Shire Hereditary Angioedema Therapeutic Product
    Table 65. Shire Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 66. Shire Recent Development
    Table 67. Attune Pharma Company Detail
    Table 68. Attune Pharma Business Overview
    Table 69. Attune Pharma Hereditary Angioedema Therapeutic Product
    Table 70. Attune Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 71. Attune Pharma Recent Development
    Table 72. Adverum Biotechnologies Company Detail
    Table 73. Adverum Biotechnologies Business Overview
    Table 74. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product
    Table 75. Adverum Biotechnologies Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 76. Adverum Biotechnologies Recent Development
    Table 77. KalVista Pharma Company Detail
    Table 78. KalVista Pharma Business Overview
    Table 79. KalVista Pharma Hereditary Angioedema Therapeutic Product
    Table 80. KalVista Pharma Revenue in Hereditary Angioedema Therapeutic Business (2017-2022) & (US$ Million)
    Table 81. KalVista Pharma Recent Development
    Table 82. Research Programs/Design for This Report
    Table 83. Key Data Information from Secondary Sources
    Table 84. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hereditary Angioedema Therapeutic Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Features
    Figure 3. Subcutaneous Features
    Figure 4. Oral Features
    Figure 5. Global Hereditary Angioedema Therapeutic Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Hereditary Angioedema Therapeutic Report Years Considered
    Figure 10. Global Hereditary Angioedema Therapeutic Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Hereditary Angioedema Therapeutic Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Hereditary Angioedema Therapeutic Market Share by Region: 2021 VS 2028
    Figure 13. Global Hereditary Angioedema Therapeutic Market Share by Players in 2021
    Figure 14. Global Top Hereditary Angioedema Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Hereditary Angioedema Therapeutic Revenue in 2021
    Figure 16. North America Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Hereditary Angioedema Therapeutic Market Share by Country (2017-2028)
    Figure 18. United States Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hereditary Angioedema Therapeutic Market Share by Country (2017-2028)
    Figure 22. Germany Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Hereditary Angioedema Therapeutic Market Share by Region (2017-2028)
    Figure 30. China Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Hereditary Angioedema Therapeutic Market Share by Country (2017-2028)
    Figure 38. Mexico Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Hereditary Angioedema Therapeutic Market Share by Country (2017-2028)
    Figure 42. Turkey Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Hereditary Angioedema Therapeutic Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. BioCryst Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 45. Ionis Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 46. Pharming Group Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 47. CSL Limited Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 48. Shire Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 49. Attune Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 50. Adverum Biotechnologies Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 51. KalVista Pharma Revenue Growth Rate in Hereditary Angioedema Therapeutic Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Frequently Asked Questions
Hereditary Angioedema Therapeutic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hereditary Angioedema Therapeutic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hereditary Angioedema Therapeutic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Medical Writing

Medical Writing market is segmented by players, region (country), by Type and by Application. Pla ... Read More